SANO STEMEDICA

Who We Are

Sano Stemedica is a global biotechnology company that has acquired Stemedica Cell Technologies, Inc.(Stemedica)’s best-in-class allogeneic adult stem cells and stem cell factors. Stemedica is a government licensed manufacturer of cGMP, clinical-grade stem cells currently used in US-based and global clinical trials. Stemedica has FDA Investigational New Drug Approvals for acute myocardial infarction, chronic heart failure, cutaneous photoaging, ischemic stroke, traumatic brain injury and Alzheimer’s disease.

Sano Stemedica’s products are also used on a worldwide basis by research institutions and hospitals for pre-clinical and clinical (human) trials. Sano Stemedica is currently developing additional clinical trials for other medical indications using adult, allogeneic stem cell under the auspices of the FDA and other international regulatory agencies.